PN NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Skycorp Solar Group Limited Ordinary Shares · Technology · Solar

Open interactive chart View report data
Latest close 17.27 USD
116.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 121.5% above the Trend Line and sits at 21.8% of its 52-week range. The latest completed week returned 116.4%, after a 345.1% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 55/100.

Setup score 50 out of 100
Latest Close 17.27 USD 31 Jul 2026
1W Return 116.4% latest completed week
4W Return 345.1% short-term follow-through
12W Return 197.2% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 44.38% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 116.4% Latest completed week; four-week move 345.1%. Indicator stack 0/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 44.38% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 55/100 56 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 121.5% above the Trend Line and sits at 21.8% of its 52-week range. The latest completed week returned 116.4%, after a 345.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0712-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 345.1% over four weeks, 197.2% over 12 weeks, and -73.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W116.4%
4W345.1%
12W197.2%
26W41.6%
52W-73.8%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.97Latest activity-pressure read.
Pressure change4990.7%Four-week change in activity pressure.
Leadership28.15Latest relative-leadership reading.
RS change135.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 85% Model confidence 69%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength2/100Blend of value, momentum, and quality. Underlying universe rank 99; rank 1 is best.
Value21/100Relative valuation strength. Underlying universe rank 80; rank 1 is best.
Quality7/100Profitability and accounting quality. Underlying universe rank 94; rank 1 is best.
Momentum1/100Medium-term price momentum. Underlying universe rank 100; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.8x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
10.0%
Gross profit retained from each unit of revenue.
Operating margin
-3.1%
Operating profit retained from revenue.
Free-cash-flow margin
5.4%
Free cash flow generated from revenue.
Return on invested capital
-9.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
27.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
69.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-7.2%
Net share repurchases relative to market value.
Shareholder yield
-7.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 56 relevant articles.

16 positive · 37 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-75.8%Distance below the 52-week high.
13-week volatility47.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+116.4%Week of 31 Jul.
Worst week-74.1%Week of 3 Apr.
Latest week+116.4%Week of 31 Jul.

Shape of recent returns

Strong gains11
Modest gains3
Flat weeks0
Modest losses1
Sharp losses11
Recent vol47.7%13-week weekly-return volatility.
Base vol31.9%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew23.1% / -16.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape42/100

Trend, activity pressure, participation, and risk combine to a 42/100 tape read.

 Indicator analysis22/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 1/12.

Activity pressure 0.07; No reversal markers Next-Week ExpectancyNegative 44.38%

Next-week expectancy is negative with a 44.38% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors6/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 84; Small Cap Core rank 86 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment55/100

Weighted news tone is neutral across 56 relevant articles.

Nasdaq, S&P 500 Futures Subdued Despite Tech Strength: Why GME, EBAY, NVDA, SOUN, PN Are In Focus Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202617.27 USD116.4%7.80 USD25.61 USD0.9728.159.6MOff
24 Jul 20267.98 USD94.2%7.70 USD25.72 USD0.73-45.5214.6MOff
17 Jul 20264.11 USD9.9%7.91 USD25.97 USD0.42-74.79139.8KOff
10 Jul 20263.74 USD-3.6%8.28 USD26.27 USD0.17-79.3939.4KOff
3 Jul 20263.88 USD4.3%8.69 USD26.60 USD-0.02-79.5292.5KOff
26 Jun 20263.72 USD3.0%9.07 USD26.93 USD-0.08-81.27185.1KOff
19 Jun 20263.61 USD-13.4%9.48 USD27.27 USD-0.07-83.65228.2KOff
12 Jun 20264.17 USD40.9%9.89 USD27.62 USD-0.06-81.8012.7MOff
5 Jun 20262.96 USD-21.1%10.28 USD27.98 USD-0.11-87.51220.5KOff
29 May 20263.75 USD-8.8%10.59 USD28.36 USD0.01-85.74237.7KOff
22 May 20264.11 USD-4.6%10.94 USD28.74 USD0.02-84.78210.1KOff
15 May 20264.31 USD-25.8%11.25 USD29.14 USD-0.12-84.68823.4KOff
8 May 20265.81 USD102.8%11.58 USD29.54 USD-0.19-80.2870.7MOff
1 May 20262.87 USD20.4%11.86 USD29.93 USD-0.28-90.1715.7MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.